117 related articles for article (PubMed ID: 23385210)
1. Design and synthesis of imidazole and triazole derivatives as Lp-PLA₂ inhibitors and the unexpected discovery of highly potent quaternary ammonium salts.
Wang K; Xu W; Liu Y; Zhang W; Wang W; Shen J; Wang Y
Bioorg Med Chem Lett; 2013 Mar; 23(5):1187-92. PubMed ID: 23385210
[TBL] [Abstract][Full Text] [Related]
2. Regioselectivity of thiouracil alkylation: Application to optimization of Darapladib synthesis.
Guibbal F; Bénard S; Patché J; Meneyrol V; Couprie J; Yong-Sang J; Meilhac O; Jestin E
Bioorg Med Chem Lett; 2018 Feb; 28(4):787-792. PubMed ID: 29336874
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Potent and Orally Active Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Inhibitors as a Potential Therapy for Diabetic Macular Edema.
Chen X; Wang K; Xu W; Ma Q; Chen M; Du L; Mo M; Wang Y; Shen J
J Med Chem; 2016 Mar; 59(6):2674-87. PubMed ID: 26927682
[TBL] [Abstract][Full Text] [Related]
4. Structural and Thermodynamic Characterization of Protein-Ligand Interactions Formed between Lipoprotein-Associated Phospholipase A2 and Inhibitors.
Liu Q; Chen X; Chen W; Yuan X; Su H; Shen J; Xu Y
J Med Chem; 2016 May; 59(10):5115-20. PubMed ID: 27078579
[TBL] [Abstract][Full Text] [Related]
5. Triazole derivatives: a series of Darapladib analogues as orally active Lp-PLA2 inhibitors.
Wang K; Xu W; Zhang W; Mo M; Wang Y; Shen J
Bioorg Med Chem Lett; 2013 May; 23(10):2897-901. PubMed ID: 23575276
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a Novel Series of Imidazo[1,2-a]pyrimidine Derivatives as Potent and Orally Bioavailable Lipoprotein-Associated Phospholipase A2 Inhibitors.
Chen X; Xu W; Wang K; Mo M; Zhang W; Du L; Yuan X; Xu Y; Wang Y; Shen J
J Med Chem; 2015 Nov; 58(21):8529-41. PubMed ID: 26479945
[TBL] [Abstract][Full Text] [Related]
7. Microwave-assisted one-pot synthesis and anti-biofilm activity of 2-amino-1H-imidazole/triazole conjugates.
Steenackers H; Ermolat'ev D; Trang TT; Savalia B; Sharma UK; De Weerdt A; Shah A; Vanderleyden J; Van der Eycken EV
Org Biomol Chem; 2014 Jun; 12(22):3671-8. PubMed ID: 24763714
[TBL] [Abstract][Full Text] [Related]
8. Enhanced antioxidant and antifungal activity of chitosan derivatives bearing 6-O-imidazole-based quaternary ammonium salts.
Wei L; Li Q; Chen Y; Zhang J; Mi Y; Dong F; Lei C; Guo Z
Carbohydr Polym; 2019 Feb; 206():493-503. PubMed ID: 30553350
[TBL] [Abstract][Full Text] [Related]
9. The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.
Mohler ER; Ballantyne CM; Davidson MH; Hanefeld M; Ruilope LM; Johnson JL; Zalewski A;
J Am Coll Cardiol; 2008 Apr; 51(17):1632-41. PubMed ID: 18436114
[TBL] [Abstract][Full Text] [Related]
10. [Role of secreted and lipoprotein-associated phospholipase A2 in cardiovascular risk].
Ferri N; Corsini A
G Ital Cardiol (Rome); 2014 Dec; 15(12):664-9. PubMed ID: 25533115
[TBL] [Abstract][Full Text] [Related]
11. Darapladib.
Bui QT; Wilensky RL
Expert Opin Investig Drugs; 2010 Jan; 19(1):161-8. PubMed ID: 20001561
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of new difluoromethyl azoles as antileishmanial agents.
Ferreira SB; Costa MS; Boechat N; Bezerra RJ; Genestra MS; Canto-Cavalheiro MM; Kover WB; Ferreira VF
Eur J Med Chem; 2007; 42(11-12):1388-95. PubMed ID: 17445951
[TBL] [Abstract][Full Text] [Related]
13. Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque.
Serruys PW; García-García HM; Buszman P; Erne P; Verheye S; Aschermann M; Duckers H; Bleie O; Dudek D; Bøtker HE; von Birgelen C; D'Amico D; Hutchinson T; Zambanini A; Mastik F; van Es GA; van der Steen AF; Vince DG; Ganz P; Hamm CW; Wijns W; Zalewski A;
Circulation; 2008 Sep; 118(11):1172-82. PubMed ID: 18765397
[TBL] [Abstract][Full Text] [Related]
14. Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation.
Saberi MR; Vinh TK; Yee SW; Griffiths BJ; Evans PJ; Simons C
J Med Chem; 2006 Feb; 49(3):1016-22. PubMed ID: 16451067
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, antimicrobial evaluation and spectroscopic characterization of novel imidazolone, triazole and triazinone derivatives.
Abu-Melha S
Spectrochim Acta A Mol Biomol Spectrosc; 2012 Oct; 96():898-905. PubMed ID: 22796528
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibitors and tailored activity probes for lipoprotein-associated phospholipase A(2).
Nagano JM; Hsu KL; Whitby LR; Niphakis MJ; Speers AE; Brown SJ; Spicer T; Fernandez-Vega V; Ferguson J; Hodder P; Srinivasan P; Gonzalez TD; Rosen H; Bahnson BJ; Cravatt BF
Bioorg Med Chem Lett; 2013 Feb; 23(3):839-43. PubMed ID: 23260346
[TBL] [Abstract][Full Text] [Related]
17. Rational design of 4-aryl-1,2,3-triazoles for indoleamine 2,3-dioxygenase 1 inhibition.
Röhrig UF; Majjigapu SR; Grosdidier A; Bron S; Stroobant V; Pilotte L; Colau D; Vogel P; Van den Eynde BJ; Zoete V; Michielin O
J Med Chem; 2012 Jun; 55(11):5270-90. PubMed ID: 22616902
[TBL] [Abstract][Full Text] [Related]
18. Tuning of redox potentials for the design of ruthenium anticancer drugs -- an electrochemical study of [trans-RuCl(4)L(DMSO)](-) and [trans-RuCl(4)L(2)](-) complexes, where L = imidazole, 1,2,4-triazole, indazole.
Reisner E; Arion VB; Guedes da Silva MF; Lichtenecker R; Eichinger A; Keppler BK; Kukushkin VY; Pombeiro AJ
Inorg Chem; 2004 Nov; 43(22):7083-93. PubMed ID: 15500346
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships for NAMI-A-type complexes (HL)[trans-RuCl4L(S-dmso)ruthenate(III)] (L = imidazole, indazole, 1,2,4-triazole, 4-amino-1,2,4-triazole, and 1-methyl-1,2,4-triazole): aquation, redox properties, protein binding, and antiproliferative activity.
Groessl M; Reisner E; Hartinger CG; Eichinger R; Semenova O; Timerbaev AR; Jakupec MA; Arion VB; Keppler BK
J Med Chem; 2007 May; 50(9):2185-93. PubMed ID: 17402720
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of novel aliphatic amido/sulfonamido-quaternary ammonium salts as antitumor agents.
Song D; Yang JS; Kim SJ; Kim BK; Park SK; Won M; Lee K; Kim HM; Choi KY; Lee K; Han G
Bioorg Med Chem; 2013 Feb; 21(3):788-94. PubMed ID: 23266181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
